Pharvaris Netherlands B.v.

This study tested an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE), a rare genetic condition. The trial involved 134 adolescents and adults aged 12 to 75 who took either the drug or a placebo at the start of a…

This study tested an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE) types I and II. 74 adults received either one of three doses of the drug or a placebo during an attack. The main goal was to see if the drug r…